NLS Pharmaceutics AG: NLS Pharmaceutics Appoints Keith Harrison Dewedoff as Interim Chief Financial Officer
ZÜRICH, SWITZERLAND / ACCESSWIRE / May 8, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and
Alex Zwyer Keith Harrison Dewedoff Marianne Lambertson Kaizen Bioscience Kellogg College Pharmaceutics Ltd
Source: finanznachrichten.de